Impaired diffusing capacity for carbon monoxide in children with type 1 diabetes: is this the first sign of long-term

Andrea E Scaramuzza1, Marco Morelli, Maurizio Rizzi

  • 1Department of Paediatrics, "Luigi Sacco Hospital", University of Milano, Milan, Italy. scaramuzza.andrea@hsacco.it

Acta Diabetologica
|November 23, 2011
PubMed

Insights

Children with type 1 diabetes show reduced lung diffusing capacity for carbon monoxide (DLCO), specifically in pulmonary capillary blood volume (Vc). This suggests potential microvascular complications, warranting DLCO screening in diabetic children.

Area of Science:

  • Pediatric Endocrinology
  • Pulmonary Medicine
  • Diabetic Complications

Background:

  • Type 1 diabetes (T1D) can lead to microvascular complications.
  • Lung dysfunction, particularly reduced diffusing capacity of the lung for carbon monoxide (DLCO), is a potential complication.
  • Understanding early lung changes in T1D is crucial for timely intervention.

Purpose of the Study:

  • To assess lung dysfunction in children with T1D.
  • To evaluate the components of DLCO: membrane diffusing capacity (DM) and pulmonary capillary blood volume (Vc).
  • To investigate potential early microangiopathic changes in the lungs of T1D patients.

Main Methods:

  • Recruited 42 children with T1D and 30 healthy controls.
  • Assessed lung volumes and spirometry using plethysmography.
  • Measured single-breath DLCO and calculated DM and Vc.

Main Results:

  • Children with T1D had reduced lung volumes compared to controls.
  • Overall DLCO was significantly lower in T1D patients (78% ± 16%) versus controls (120% ± 1%).
  • Impairment was specifically noted in Vc (34 ± 20 ml vs. 88 ± 18 ml), while DM showed no significant difference.

Conclusions:

  • Reduced Vc in T1D children may indicate early microangiopathic changes.
  • DLCO impairment, particularly Vc, could be an early sign of lung involvement in T1D.
  • Screening DLCO in all patients with type 1 diabetes is recommended.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...